Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abx196 (1 trial)
act-001 (1 trial)
pembrolizumab (keytruda) (1 trial)
hdt-301 (1 trial)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Trials (3 total)
Trial APIs (4 total)